Clinical Trial Update: Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CP-751,871 in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced non-small cell lung cancer; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CP-751,871 (dalotuzumab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2013-02-25